
Stay Updated with the Latest Lumexa Imaging Holdings, Inc. Common Stock LMRI News in Real Time
Find LMRI news now at Meyka AI. Stay informed with the latest Lumexa Imaging Holdings, Inc. Common Stock stocks updates, including price news, market analysis, and expert insights.

BLS International (NSE: BLS) Sinks 13% to ₹236 Amid Spanish Visa Fraud Investigation; Firm Denies Wrongdoing
BLS International shares fell nearly 14% to ₹233.47 on the NSE on August 24, 2026, after reports linked the company to an expanded Spanish National Court investigation into alleged visa fraud in Algiers. The sharp decline has put the BLS share price under fresh pressure. BLS International has denied any wrongdoing. The company said its…

Hindustan Zinc (NSE: HINDZINC) Advances 2.5% to ₹609.60, Extends Rally to Third Straight Session
Hindustan Zinc shares rose 2.47% to ₹609.60 on Monday, August 24, 2026. The stock extended its rally to a third consecutive session, outperforming the broader market. Hindustan Zinc is up 40.23% over the past year, against a 3.13% drop in the Nifty 50. Silver Strength Keeps Driving the Rally Hindustan Zinc’s Q1 FY27 results, released…

FTSE 100 Today: UK Stocks Dip as Iran Sanctions ‘Economic D-Day’ and Asian Tech Rout Cloud Markets
On August 24, 2026, the FTSE 100 today came under pressure as investors weighed tougher US sanctions on Iran alongside a sharp selloff in Asian technology stocks. The index initially slipped as markets waited for details of Washington’s measures. South Korea’s KOSPI fell 3.12%, while Hong Kong’s Hang Seng dropped about 2%. Oil prices also…

Heranba Industries (NSE: HERANBA) Jumps 9.5% to ₹180.60 on ₹25 Crore Agrochem Unit Investment
Heranba Industries shares jumped 9.53% to ₹180.60 on Monday, August 24, 2026. The rally followed a Q1 FY27 profit turnaround alongside a fresh ₹25 crore investment plan. Heranba Industries also returned to profitability after a weak Q4 FY26. Q1 FY27 Results Drive the Rally Heranba Industries (HERANBA.NS) posted consolidated net profit of ₹7.14 crore in…

XRP vs RLUSD: Can Ripple’s Banking Expansion Drive Long-Term Token Demand?
XRP trades near $1.57 in late August 2026, after rallying from $1.00 in under two weeks. The move sits alongside rapid growth in RLUSD, Ripple’s own stablecoin. Investors now ask whether Ripple’s banking expansion actually pulls demand toward XRP, or toward RLUSD instead. XRP’s August Rally, By the Numbers XRP climbed from $1.00 to above…

Xiaomi (HK: 1810) Launches In-House Xring O3 Chip and Partners with TSMC for Production
Xiaomi unveiled its Xring O3 chip on August 24, 2026, adding another in-house processor to its growing semiconductor effort. Sources familiar with the plans say TSMC will manufacture the chip using 3nm technology. The processor is expected to power Xiaomi’s next flagship foldable, with initial shipments estimated at 200,000 to 300,000 units. Developing its own…

Sony Faces PlayStation Blackout as Gamers Protest Disc Phase-Out by 2028
PlayStation gamers boycott Sony through August 30 over plans to end physical disc production in 2028. Sony’s licensing emails spark debate on digital ownership rights.

Shein Targets $27B (£20B) Valuation in Long-Awaited Hong Kong IPO, Raising to $1.8B
Shein launched its Hong Kong IPO on Monday, August 24, 2026, targeting a valuation of up to 27billion.Thefast-fashionretaileraimstoraiseasmuchasHK13.86 billion, or 1.77billion.ShareswillpricebetweenHK47.60 and HK$49.50 apiece. IPO Structure and Timeline Shein is selling 280 million Class B shares in the offering. The company will confirm its final IPO price on August 31, 2026. Trading on the Hong…

Hanmi Pharm (KRX: 128940) Hits 30% Daily Limit on $2.3B Obesity Drug Licensing Deal with Genentech
Hanmi Pharm shares surged 30% on August 24, 2026, hitting the daily price limit after the South Korean drugmaker announced a licensing deal with Genentech worth up to $2.3 billion. The agreement covers HM17321, an experimental obesity treatment designed to reduce body fat while preserving muscle mass. Hanmi will receive $190 million upfront, while Genentech…